Evidence map›Paper›PMID 36690628›Full record

ArticleBlood cancer journal2023

Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies.

Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Satoshi Yoshioka, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo and 11 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Masashi NishikuboDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Yoshimitsu ShimomuraDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan. shimomura_0119@yahoo.co.jp.ORCID 0000-0003-1018-9508
Ryusuke YamamotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Satoshi YoshiokaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.ORCID 0000-0003-3664-6324
Hayato MaruokaDepartment of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Seiko NasuDepartment of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Tomomi NishiokaLSI Medience Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Kenji SakizonoDepartment of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Satoshi MitsuyukiDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Tomoyo KuboDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Naoki OkadaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Daishi NakagawaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Kimimori KamijoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Hiroharu ImotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Yuya NagaiDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Noboru YonetaniDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Tadakazu KondoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.ORCID 0000-0002-8959-6271
Chisato MiyakoshiDepartment of Research Support, Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.ORCID 0000-0001-6882-7053
Asako DoiDepartment of Infectious diseases, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.
Takayuki IshikawaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Humans

Identifiers

PMID36690628
PMCPMC9868506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.